# Safety and Efficacy Study of Target Therapy Combined With Radiotherapy to Treat Senile Locally Advanced SCCHN

> **NCT01393184** · PHASE2 · UNKNOWN · sponsor: **Peking University** · enrollment: 92 (estimated)

## Conditions studied

- SCCHN

## Interventions

- **DRUG:** Nimotuzumab and Radiotherapy

## Key facts

- **NCT ID:** NCT01393184
- **Lead sponsor:** Peking University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-03
- **Primary completion:** 2013-02
- **Final completion:** 2013-03
- **Target enrollment:** 92 (ESTIMATED)
- **Last updated:** 2011-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01393184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01393184, "Safety and Efficacy Study of Target Therapy Combined With Radiotherapy to Treat Senile Locally Advanced SCCHN". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT01393184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*